AMSTERDAM (Reuters) - An independent Dutch foundation linked to generic drugs manufacturer Mylan used a poison pill to try and block a $40 billion takeover bid by Israeli rival Teva , citing potential ...
The battle over generic rights to Pfizer's blockbuster blood pressure pill Norvasc slogs on, with a new chalk mark in favor of Mylan Laboratories. First, a short recap. Mylan has been selling copycat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback